Citicoline vs standard methods versus placebo
Death during study period · people with acute ischemic stroke
Citicoline showed no clear difference in all‐cause mortality (at any time of trial) compared with placebo or standard treatment (low certainty).
1 finding from 1 review
- RR 0.94 [0.83, 1.07]8 studies · 4362 participantsLow